Drugs for Neglected Diseases initiative - DNDi

The Drugs for Neglected Diseases initiative - DNDi is an international, non-profit research and development organization dedicated to discovering, developing, and delivering life-saving treatments for neglected patients worldwide. With a strong commitment to affordability and patient-friendliness, DNDi has already impacted millions of lives through its innovative approaches to drug development.

Operating from its primary address at 15 Chemin Camille-Vidart, Geneva, 1202, CH, and with additional locations including George Padmore Road, Nairobi, Kilimani 254, KE; Avenue Milambo 4, Commune de la Gombe, Kinshasa 0, CD; 4/2 Siri Institutional Area, PHD House, 3rd Floor, New Delhi, New Delhi 110016, IN; 6-12-1 Nishi-Shinjuku, 3F Parkwest Bldg, Tokyo, Tokyo 160-0023, JP; Rua São Jose 70, Sala 601, Centro, Rio de Janeiro, Rio de Janeiro 20010-020, BR; 40 Rector Street, 16th Floor, New York, New York 10006, US; Francie van Zijl Dr, Parow Valley, Cape Town, Cap-Ouest 7501, ZA; and L10-7, Menara Sentral Vista, 150, Jln Sultan Abdul Samad, Brickfields, Kuala Lumpur, Kuala Lumpur 50470, MY, DNDi focuses on researching and developing treatments for diseases such as Chagas disease, sleeping sickness, leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. DNDi is actively engaged in over 40 projects, including more than 20 new chemical entities and over 20 clinical trials.

The Drugs for Neglected Diseases initiative - DNDi continues to expand its reach and impact through strategic partnerships and a commitment to open innovation. DNDi is dedicated to addressing the unmet medical needs of the most vulnerable populations. We invite the management team of Drugs for Neglected Diseases initiative - DNDi to create a customized and exclusive company showcase and product listing on our platform to further enhance their global visibility and collaborative opportunities.